Wiskott-Aldrich Syndrome (WAS) is a serious medical condition that causes problems both with the immune system and with blood clotting. The immune abnormalities cause WAS patients to be very susceptible to infections with bacterial, fungal, and viral organisms. The problems with easy bruising and bleeding in WAS patients result from having low numbers of small, non-functional platelets, the cells in the blood that clump together to form blood clots.
Success Rates
If your child's condition requires a bone-marrow transplant, you should know that the Fred Hutchinson Transplant program at SCCA was ranked first in outcomes in a four-year study by the National Marrow Donor Program (NMDP) that measured one-year survival rates of patients among 122 transplant centers in the United States. The Hutchinson Center pioneered the use of bone-marrow transplants as a treatment for blood diseases over 40 years ago. Since then thousands of patients with leukemia have come from around the world to receive bone-marrow transplants at SCCA. Bone-marrow transplants have transformed leukemia and related cancers, once thought incurable, into highly treatable diseases with survival rates as high as 80 percent.
Learn about the risk factors and symptoms of Wiskott-Aldrich Syndrome (WAS), how it is diagnosed and how its stages are determined.
Regardless of the stage of your illness, the unsurpassed expertise of our physicians makes SCCA the ideal treatment center for Wiskott-Aldrich Syndrome (WAS).
Our doctors are members of Fred Hutchinson Cancer Research Center and faculty from UW Medicine and Seattle Children's. They are the best of the best who work as a team to care for people with Wiskott-Aldrich Syndrome(WAS).
As a world-class treatment center, SCCA provides patients with the best and most current therapies available. Clinical studies bring promising new treatments to patients faster. And participating in a study gives patients at least the best, current treatment, as well as the satisfaction that they are helping others with Wiskott-Aldrich Syndrome (WAS).
Because treatment for Wiskott-Aldrich Syndrome (WAS) isn't easy, special support for patients is essential. SCCA has several programs, classes, and services to assist patients and their families.
Receiving a diagnosis for Wiskott-Aldrich Syndrome (WAS) leads to many questions. SCCA physicians and staff provide compassionate care and support during your course of treatment so you will always know what to expect.
Read about amazing people who have gone through treatment for cancer at Seattle Cancer Care Alliance.
The more you know about your disease, the more empowered you'll feel. This list of reputable sources about Wiskott-Aldrich Syndrome (WAS) makes gathering information easy.
